Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC35682 CHMFL-ABL/KIT-155

    CHMFL-ABL-KIT-155

    CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155; compound 34) 是一种高效的,具有口服活性的 type II ABL/c-KIT 双激酶抑制剂 (IC50 分别为 46 nM 和 75 nM),对 BLK (IC50=81 nM), CSF1R (IC50=227 nM), DDR1 (IC50=116 nM), DDR2 (IC50=325 nM), LCK (IC50=12 nM), PDGFRβ (IC50=80 nM) 激酶也具有明显的抑制活性。CHMFL-ABL/KIT-155 (CHMFL-ABL-KIT-155) 阻止细胞周期进展和诱导细胞凋亡。
  3. GC35668 CG-200745

    CG-200745

    CG-200745 (CG-200745) 是一种具有口服活性的强效 pan-HDAC 抑制剂,其异羟肟酸部分可与催化袋底部的锌结合。 CG-200745 抑制组蛋白 H3 和微管蛋白的去乙酰化。 CG-200745 诱导 p53 的积累,促进 p53 依赖性反式激活,并增强 MDM2 和 p21 (Waf1/Cip1) 蛋白的表达。 CG-200745 增强了吉西他滨耐药细胞对吉西他滨和 5-氟尿嘧啶 (5-FU;) 的敏感性。 CG-200745 诱导细胞凋亡并具有抗肿瘤作用。
  4. GC35636 CDK9-IN-7 CDK9-IN-7 (compound 21e) 是一种高效选择性的,具有口服活性的 CDK9/cyclin T 抑制剂 (IC50=11 nM),与抑制其他 CDK 相比更有效 (CDK4/cyclinD=148 nM; CDK6/cyclinD=145 nM)。CDK9-IN-7 具有抗癌活性并没有明显的毒性。CDK9-IN-7 诱导非小细胞肺癌 (NSCLC) 细胞凋亡,在 G2 期阻滞细胞周期,并具有抑制非小细胞肺癌干度的特性。
  5. GC35630 CDDO-EA

    CDDO ethyl amide; TP319; RTA 405

    CDDO-EA 是一种 NF-E2 相关因子 2 /抗氧化反应元件 (Nrf2/ARE) 激活剂。
  6. GC35629 CDDO-dhTFEA

    RTA dh404

    CDDO-dhTFEA (RTA dh404) 是一种合成的齐墩果烷三萜化合物,有效激活 Nrf2 并抑制促炎转录因子 NF-κB。 CDDO-dhTFEA 可以恢复高血压 (MAP),增加 Nrf2 及其靶基因的表达,减弱 NF-κB 的活化和转化生长因子-β 途径,并减少慢性肾病 (CKD) 大鼠的肾小球硬化,间质纤维化和炎症。
  7. GC35612 Carvacrol

    香芹酚

    A monoterpene with diverse biological activities
  8. GC35598 Camellianin A

    山茶黄酮苷 A

    Camellianin A 是 A. nitida 叶中主要的黄酮类化合物,具有抗癌活性和抗血管紧张素转换酶 (ACE) 活性。Camellianin A 能抑制人 Hep G2 和 MCF-7 细胞的增殖,诱导细胞 G0/G1 期停滞。
  9. GC35559 Bruceine D

    鸦胆子苦素D

    Bruceine D, isolated from Brucea javanica (L.) Merr. (Simaroubaceae), shows antineoplastic properties in various human cancers including pancreas, breast, lung, blood, bone, and liver. Bruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.
  10. GC35555 Britannin

    旋覆花内酯

    Britannin,分离于 Inula aucheriana,是倍半萜内酯。Britannin 通过激活由 ROS 调节的 AMPK 来诱导肝癌细胞凋亡和自噬。Britannin 具有抗增殖和抗炎活性。
  11. GC35554 Brevilin A

    短叶老鹳草素A

    A sesquiterpene lactone with anticancer activity
  12. GC35530 BJE6-106

    B106

    BJE6-106 (B106) 是一种有效的选择性 PKCδ 抑制剂,IC50 值为 0.05 μM,BJE6-106 (B106) 靶向 PKCδ 的选择性是 PKC 同工酶 PKCα 的 1000倍 (IC50=50 μM)。BJE6-106 (B106) 可以诱导 caspase 依耐性细胞凋亡 (apoptosis)。BJE6-106 (B106) 具有肿瘤特异性作用。
  13. GC35523 Bioymifi

    DR5 Activator

    A DR5 agonist
  14. GC35511 BI-0252 BI-0252 是一种具有口服活性,选择性的 MDM2-p53 抑制剂,IC50 值为 4 nM。 BI-0252 可诱导异种移植小鼠 SJSA-1 的所有动物肿瘤消退,同时诱导肿瘤蛋白p53 (TP53) 靶基因和凋亡标志物。
  15. GC35504 Beta-Zearalanol

    B-赤霉醇

    Beta-Zearalanol 是由镰刀菌属 Fusarium 产生的一种霉菌毒素,可以在哺乳动物生殖细胞中引起细胞凋亡 (apoptosis) 和氧化应激反应。 Beta-Zearalanol 是玉米赤霉烯酮(ZEA)的衍生物,可以与葡萄糖醛酸 (glucuronic acid) 结合。
  16. GC35458 Bacopaside II

    假马齿苋皂苷II

    A triterpene glycoside
  17. GC35440 AX-024 An inhibitor of the CD3ε-Nck interaction
  18. GC35415 Astramembrangenin

    环黄芪醇; Astramembrangenin; Cyclosieversigenin

    Cyclogalegenol (Astramembrangenin, Cyclosieversigenin), the aglycone derivative of astragaloside A, is found in various species of Astragalus and may activate telomerase.
  19. GC35395 Arnicolide D

    山金车内酯 D

    A sesquiterpene lactone with anticancer activity
  20. GC35388 Aristolactam I

    马兜铃内酰胺,Aristololactam; Aristolactam

    Aristololactam I (AL-I) 是马兜铃酸I (AA-I) 的主要代谢产物,参与导致肾损伤的过程。Aristololactam I (AL-I) 直接损伤肾近端小管细胞,AL-I 的细胞毒性效力高于AA-I,并且这些分子的细胞毒性作用是通过 caspase-3 依赖性细胞凋亡介导。
  21. GC35377 Apratastat

    N-羟基-4-[[4-[(4-羟基-2-丁炔基)氧基]苯基]磺酰基]-2,2-二甲基-3-硫代吗啉甲酰胺,TMI-005

    An inhibitor of ADAM17 and MMPs
  22. GC35367 APG-115

    AA-115

    APG-115 (APG-115) 是一种具有口服活性的 MDM2 蛋白抑制剂,与 MDM2 蛋白结合,IC50 和 Ki 值分别为 3.8 nM 和 1 nM。 APG-115 阻断 MDM2 和 p53 的相互作用,并以 p53 依赖性方式诱导细胞周期停滞和细胞凋亡。
  23. GC35361 Antineoplaston A10

    3-苯基乙酰氨基-2,6-哌啶二酮

    Antineoplaston A10 is a naturally occurring substance in the human body that that can be potentially used for the treatment of glioma, lymphoma, astrocytoma and breast cancer. The main ingredient active of antineoplaston A10 (Phenylacetylglutamine, PG) inhibits RAS and promotes apoptosis.
  24. GC35306 alpha-Mangostin

    α-倒捻子素; α-Mangostin

    A xanthone with diverse biological activities
  25. GC35305 α-Bisabolol

    alpha-红没药醇

    A sesquiterpene alcohol with anticancer activity
  26. GC35288 Alkannin

    左旋紫草素

    A naphthoquinone with diverse biological activities
  27. GC35275 AKT-IN-3 AKT-IN-3 (compound E22) 是一种有效、口服的低 hERG 阻断 Akt 抑制剂,对 Akt1、Akt2 和 Akt3 作用的 IC50 值分别为 1.4 nM、1.2 nM 和 1.7 nM。AKT-IN-3 (compound E22) 对其他 AGC 家族激酶也有较好的抑制活性,如 PKA、PKC、ROCK1、RSK1、P70S6K、SGK。AKT-IN-3 (compound E22) 能诱导癌细胞凋亡,抑制癌细胞的转移。
  28. GC35242 Actein

    黄肉楠碱

    Actein 是从 Cimicifuga foetida 的根茎中分离的三萜糖苷。Actein 通过促进 ROS/JNK 活化和钝化人膀胱癌中的 AKT 途径来抑制细胞增殖,诱导自噬和凋亡。Actein 在体内几乎没有毒性。
  29. GC35227 ACBI1 ACBI1 is a potent and cooperative PROTAC degrader of SMARCA2, SMARCA4 and PBRM1 with DC50 of 6 nM, 11 nM and 32 nM for SMARCA2, SMARCA4 and PBRM1 in MV-4-11 cells, respectively. ACBI1 is composed of a bromodomain ligand, a linker, and the E3 ubiquitin ligase VHL. ACBI1 induces anti-proliferative effects and apoptosis.
  30. GC35216 AAPK-25 AAPK-25 是一种有效选择性的 Aurora/PLK 激酶双重抑制剂,具有抗肿瘤活性。AAPK-25 可引起有丝分裂延迟并阻滞前中期细胞,通过生物标志物组蛋白 H3Ser10 磷酸化反应,随后细胞凋亡激增。AAPK-25 靶向 Aurora-A, -B, -C 的 Kd 值为 23 nM-289 nM,靶向 PLK-1, -2, -3 的 Kd 值为 55-456 nM。
  31. GC35190 7-Ethylcamptothecin

    7-乙基喜树碱

    An anticancer agent
  32. GC35184 7,3',4'-Tri-O-methylluteolin

    木犀草素-7,3',4'-三甲醚; 5-Hydroxy-3',4',7-trimethoxyflavone

    7,3',4'-Tri-O-methylluteolin (5-Hydroxy-3',4',7-trimethoxyflavone) 是一种来自草药马鞭草科 (Lippia nodiflora L.) 的类黄酮,Lippia nodiflora L. 已被证明具有抗炎,解热,镇咳,抗糖尿病,抗癌和抗黑素生成特性。7,3',4'-Tri-O-methylluteolin 以浓度依赖方式明显抑制促炎细胞因子,如 TNF-α,IL-6 和 IL-1β。7,3',4'-Tri-O-methylluteolin 显著降低在转录水平的诱导型一氧化氮合酶和环加氧酶-2 的 mRNA 表达。
  33. GC35150 5,7,4'-Trimethoxyflavone

    5,7,4'-三甲氧基黄酮

    4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein.
  34. GC35147 5-(N,N-Hexamethylene)-amiloride

    阿米洛利,Hexamethylene amiloride; HMA

    An amiloride derivative with diverse biological activities
  35. GC35138 4-Methyldaphnetin

    4-甲基瑞香素

    7,8-Dihydroxy-4-methylcoumarin (DHMC) is a precursor in the synthesis of derivatives of 4-methyl coumarin, which has excellent radical scavenging properties.
  36. GC35112 3'-Hydroxypterostilbene

    3’-羟基紫檀茋

    3'-Hydroxypterostilbene (3'-HPT) is one of the active constituents of Sphaerophysa salsula and Pterocarpus marsupium which may be useful in treating different types of haematological malignancies. 3'-Hydroxypterostilbene, a natural pterostilbene analogue, effectively inhibits the growth of human colon cancer cells (IC50s of 9.0, 40.2, and 70.9 ?M for COLO 205, HCT-116, and HT-29 cells, respectively) by inducing apoptosis and autophagy. 3'-Hydroxypterostilbene inhibits the PI3K/Akt/mTOR/p70S6K, and p38MAPK pathways and activates the ERK1/2, JNK1/2 MAPK pathways.
  37. GC35106 3-Dehydrotrametenolic acid

    3-氢化去氢松苓酸

    3-?Dehydrotrametenolic acid,分离于茯苓菌核,是一种乳酸脱氢酶 (LDH) 抑制剂。3-?Dehydrotrametenolic acid 促进体外脂肪细胞分化,在体内起胰岛素增敏剂的作用。3-?Dehydrotrametenolic acid 诱导细胞凋亡,具有抗癌活性。
  38. GC35099 3-O-Acetyloleanolic acid

    齐墩果酸3-乙酸酯

    A triterpene with diverse biological activities
  39. GC35057 14-Deoxyandrographolide

    14-去氧穿心莲内酯

    A diterpene lactone with diverse biological properties
  40. GC35013 [8]-Shogaol

    8-姜烯酚

    [8]-Shogaol,生姜中的一种刺激性酚类化合物,具有抗血小板活性 (IC50=5 μM) 和抑制 COX-2 (IC50=17.5 μM)。[8]-Shogaol 诱导人白血病细胞凋亡。
  41. GC35001 (S)-Gossypol acetic acid

    (S)-(+)-Gossypol acetic acid

    (S)-Gossypol acetic acid 是天然产物 Gossypol 的异构体。(S)-Gossypol 以高亲和力结合到 Bcl-xL 和 Bcl-2 蛋白的 BH3 结合沟。
  42. GC34981 (E)-Flavokawain A

    卡瓦胡椒素A

    A chalcone with diverse biological activities
  43. GC34980 (E)-Ferulic acid

    反式阿魏酸,(E)-Coniferic acid

    Trans-ferulic acid is a potent activator of AMPKunder high glucose condition.
  44. GC34965 (20S)-Protopanaxatriol

    20 (S)-原人参三醇; 20(S)-APPT; g-PPT

    An active ginsenoside metabolite
  45. GC15291 GSK3145095 GSK3145095 是一种 RIP1 激酶抑制剂,IC50 为 6.3 nM。
  46. GC45270 (±)10(11)-EDP Ethanolamide

    10,11-EDP-EA, 10,11-EDP epoxide, 10,11-epoxy Docosapentaenoic Ethanolamide

    An ω-3 endocannabinoid epoxide and CB receptor agonist
  47. GC45265 (+)-Goniothalesdiol A natural product with cytotoxic activity
  48. GC45256 (+)-ar-Turmerone

    (6S)-2-甲基-6-(4-甲基苯基)-2-庚烯-4-酮,(+)-ar-Turmerone

    A natural compound with immunomodulatory activities
  49. GC45246 (-)-Chaetominine

    (-)-Chaetominine

    A cytotoxic alkaloid
  50. GC45244 (-)-(α)-Kainic Acid (hydrate)

    红藻氨酸

    An L-glutamate analog with neuroexcitatory activities

  51. GC45213 α-NETA

    2-(BETA-萘甲酰基)乙基三甲基碘化铵

    An inhibitor of choline acetyltransferase

Items 1151 to 1200 of 2517 total

per page

Set Descending Direction